The clinical impact of different assays for prostate specific antigen. - Wikidata - awgldk - TriplyDB

The clinical impact of different assays for prostate specific antigen.

The clinical impact of different assays for prostate specific antigen.

http://www.wikidata.org/entity/Q34022442

about

Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips.Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?Prostate biopsy in Switzerland: a representative survey on how Swiss urologists do it.Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.Standardization of assay methods reduces variability of total PSA measurements: an Irish study.Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards.

P2860

Q33365802-B91A9E7B-BB03-41DC-9417-D1F91E4A0A88 Q35831125-425A664A-13B8-4166-A4B4-4FD047F69D54 Q37602710-6F730731-1CD4-4FE5-9269-DFAAD5692052 Q39813133-FF80210A-0EB5-4A33-AEF0-201188631D3B Q50172300-E3A1C751-36A7-4183-AE80-E92EFAF8EF87 Q50561785-B589C064-6784-4203-AAA9-E89776A9D651 Q52915484-18FA04C0-B2A9-4F59-84EC-34D95CBA2297

P2860

The clinical impact of different assays for prostate specific antigen.

http://www.wikidata.org/entity/Q34022442

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

The clinical impact of different assays for prostate specific antigen.

@ast

The clinical impact of different assays for prostate specific antigen.

@en

The clinical impact of different assays for prostate specific antigen.

@nl

type

label

The clinical impact of different assays for prostate specific antigen.

@ast

The clinical impact of different assays for prostate specific antigen.

@en

The clinical impact of different assays for prostate specific antigen.

@nl

prefLabel

The clinical impact of different assays for prostate specific antigen.

@ast

The clinical impact of different assays for prostate specific antigen.

@en

The clinical impact of different assays for prostate specific antigen.

@nl

P1433

Q34022442-829B39F3-E286-4237-9A96-947C90B2B143

P1476

Q34022442-86F385AD-1671-493E-AF61-F34D2A8E0D72

P2093

Q34022442-3BE3380E-ABFB-41F4-B81C-688EF102BB73

Q34022442-99BCF795-6DCE-4D08-BFFE-0C0F75AB60F9

Q34022442-9A4C0337-D7DE-409E-BD33-BA55A8CB19C7

Q34022442-BAD83539-886B-4CFD-9A16-40E7764954D8

Q34022442-E31CC768-8F06-4279-AE68-3DF570055B74

P2860

Q34022442-053F7386-6EAE-4F4F-B4BC-AEE0C88280BC

Q34022442-3B36689B-B965-4926-918B-0438944D7829

Q34022442-5D5C36C2-21C0-4879-86D5-D003D735A226

Q34022442-7332F87A-83DA-4BB9-ADB9-95891D638379

Q34022442-8901C605-6F95-4D58-BEF7-1FA17F9A23ED

Q34022442-9321A385-0836-4E8E-93DD-3B19A4293C2B

Q34022442-95EC0A2B-9E25-4DDB-AE3D-9D185B6F6F6B

Q34022442-98E9A9EB-5E4C-4200-AF05-B997C5BF9EF2

Q34022442-9FE44642-A122-40CB-98C2-74CD5020FE8A

Q34022442-BF82734A-CA8B-4A23-9B99-0C658A836F29

P304

Q34022442-F0ACC043-B316-4FC5-82D1-BF38048A29DE

P31

Q34022442-BEAF799F-3AFB-40E6-9BC7-3521EC6D397A

P356

Q34022442-86D4DF54-4FA6-47F2-8BAF-5E78DD556057

P433

Q34022442-1BC7FBF9-6DF3-440C-AEFF-6006F041FFCB

P478

Q34022442-F911E6D3-0E11-4A89-B02F-C75221125270

P50

Q34022442-E9193A1C-2CFB-4A00-A14D-0670CB741973

P577

Q34022442-D9AEFB1B-2080-4F9E-A862-156A8793505D

P698

Q34022442-7E69040E-DC79-4103-973B-811A9D84FC87

P356

J.1464-410X.2000.00858.X

P1433

BJU International

P1476

The clinical impact of different assays for prostate specific antigen

@en

P2093

A Semjonow

http://www.w3.org/2001/XMLSchema#string

F Oberpenning

http://www.w3.org/2001/XMLSchema#string

G De Angelis

http://www.w3.org/2001/XMLSchema#string

H P Schmid

http://www.w3.org/2001/XMLSchema#string

L Hertle

http://www.w3.org/2001/XMLSchema#string

P2860

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Molecular cloning of human prostate specific antigen cDNA.

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project.

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer.

Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma.

P304

590-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1464-410X.2000.00858.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Burkhard Brandt

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10971300

http://www.w3.org/2001/XMLSchema#string